Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128769) titled 'The Effect of Kluyveromyces marxianus on Improving Allergic Rhinitis Symptoms in Adults' on July 25.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: West China Fourth Hospital of Sichuan University
Condition:
Allergic Rhinitis
Intervention:
Maxicurvi Yeast Live Bacteria Group:Maxicurvi yeast live bacteria powder, containing 5x10^9 CFU/g of yeast, 2g/day
Maxicurvi Yeast Inactivated Bacteria Group:Maxicurvi yeast inactivated bacteria powder, with yeast content of 5x10^9 CFU/g before inactivation, 2g/day
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-...